Decentralized tools and technologies will continue to provide new opportunities for patient engagement post-COVID.
Gordon Cummins
Advertisement
Articles by Gordon Cummins
Advertisement
Latest Updated Articles
Refining, Rethinking, and Decentralizing Clinical ResearchFebruary 26th 2021
Advertisement
Advertisement
Trending on PharmExec
1
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
2
Reading Between the Lines: Closing the T1D Misdiagnosis Gap
3
Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer
4
Novartis Announces $105 Million Collaborative Agreement with Antares Therapeutics
5